Paper
CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Published Apr 10, 2019 · Minjiang Chen, A. Mao, Min Xu
Cancer letters
184
Citations
3
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Highly Cited
Study Snapshot
CRISPR-Cas9 shows promise for cancer therapy, but challenges like fitness of edited cells, editing efficiency, delivery methods, and potential off-target effects need to be addressed for clinical application.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···
Citations
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···